Clinical Trial Update: Use of Platelet Rich Plasma After Arthroscopic Debridement for Triangular Fibrocartilage Complex Tears [NA]

View source ↗

Summary

A clinical trial investigating the use of Platelet Rich Plasma following arthroscopic debridement for triangular fibrocartilage complex tears has been terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthroscopic Surgery Complications
• Triangular Fibrocartilage Complex Injury

Drugs mentioned

• Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Arthroscopic Surgery, Triangular Fibrocartilage Complex Injury | NA | Status: TERMINATED | Results posted: 2022-10-06